Fluid Candidate Biomarkers for Alzheimer’s Disease: A Precision Medicine Approach
A plethora of dynamic pathophysiological mechanisms underpins highly heterogeneous phenotypes in the field of dementia, particularly in Alzheimer’s disease (AD). In such a faceted scenario, a biomarker-guided approach, through the implementation of specific fluid biomarkers individually reflecting d...
Main Authors: | Eleonora Del Prete, Maria Francesca Beatino, Nicole Campese, Linda Giampietri, Gabriele Siciliano, Roberto Ceravolo, Filippo Baldacci |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-11-01
|
Series: | Journal of Personalized Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4426/10/4/221 |
Similar Items
-
Biomarcadores de enfermedad de Alzheimer en deterioro cognitivo leve: experiencia en una clínica de memoria de Latinoamérica
by: R.F. Allegri, et al.
Published: (2021-04-01) -
A Note on Changing Approach to Diagnosis of Alzheimer’s Disease
by: Antonio Tartaglione, et al.
Published: (2013-07-01) -
Correlation between CSF biomarkers of Alzheimer’s disease and global cognition in a psychogeriatric clinic cohort
by: Márcia Radanovic, et al. -
Erlangen Score as a tool to predict progression from mild cognitive impairment to dementia in Alzheimer’s disease
by: Inês Baldeiras, et al.
Published: (2019-01-01) -
Machine Learning Profiling of Alzheimer's Disease Patients Based on Current Cerebrospinal Fluid Markers and Iron Content in Biofluids
by: Eleonora Ficiarà, et al.
Published: (2021-02-01)